Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 730 participants.

Also called NCT01412164

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 730 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01412164
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01412164. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2016-03-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)
Intervention (Device)
FIREHAWK biodegradable polymer rapamycin-eluting stent
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01412164
Content hash
7ca204722fb1a523ce15af4dd800caab285bae181a3cbd06bf57987d72aae021